Shi W - Search Results

1

MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway.

Alajez NM, Lenarduzzi M, Ito E, Hui AB, Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, O'Sullivan B, Liu FF. Alajez NM, et al. Among authors: shi w. Cancer Res. 2011 Mar 15;71(6):2381-91. doi: 10.1158/0008-5472.CAN-10-2754. Epub 2011 Mar 8. Cancer Res. 2011. PMID: 21385904

2

Molecular pathology parameters in human nasopharyngeal carcinoma.

Shi W, Pataki I, MacMillan C, Pintilie M, Payne D, O'Sullivan B, Cummings BJ, Warde P, Liu FF. Shi W, et al. Cancer. 2002 Apr 1;94(7):1997-2006. doi: 10.1002/cncr.0679. Cancer. 2002. PMID: 11932902 Free article.

3

Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling.

Shi W, Bastianutto C, Li A, Perez-Ordonez B, Ng R, Chow KY, Zhang W, Jurisica I, Lo KW, Bayley A, Kim J, O'Sullivan B, Siu L, Chen E, Liu FF. Shi W, et al. Int J Cancer. 2006 Nov 15;119(10):2467-75. doi: 10.1002/ijc.22107. Int J Cancer. 2006. PMID: 16858677 Free article.

4

Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.

Yip KW, Shi W, Pintilie M, Martin JD, Mocanu JD, Wong D, MacMillan C, Gullane P, O'Sullivan B, Bastianutto C, Liu FF. Yip KW, et al. Among authors: shi w. Clin Cancer Res. 2006 Oct 1;12(19):5726-32. doi: 10.1158/1078-0432.CCR-06-0571. Clin Cancer Res. 2006. PMID: 17020977

5

Efficacy of systemically administered mutant vesicular stomatitis virus (VSVDelta51) combined with radiation for nasopharyngeal carcinoma.

Alajez NM, Mocanu JD, Shi W, Chia MC, Breitbach CJ, Hui AB, Knowles S, Bell JC, Busson P, Takada K, Lo KW, O'Sullivan B, Gullane P, Liu FF. Alajez NM, et al. Among authors: shi w. Clin Cancer Res. 2008 Aug 1;14(15):4891-7. doi: 10.1158/1078-0432.CCR-07-4134. Clin Cancer Res. 2008. PMID: 18676763

6

Therapeutic efficacy of seliciclib in combination with ionizing radiation for human nasopharyngeal carcinoma.

Hui AB, Yue S, Shi W, Alajez NM, Ito E, Green SR, Frame S, O'Sullivan B, Liu FF. Hui AB, et al. Among authors: shi w. Clin Cancer Res. 2009 Jun 1;15(11):3716-24. doi: 10.1158/1078-0432.CCR-08-2790. Epub 2009 May 26. Clin Cancer Res. 2009. PMID: 19470731

7

Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer.

Shi W, Alajez NM, Bastianutto C, Hui AB, Mocanu JD, Ito E, Busson P, Lo KW, Ng R, Waldron J, O'Sullivan B, Liu FF. Shi W, et al. Int J Cancer. 2010 May 1;126(9):2036-48. doi: 10.1002/ijc.24880. Int J Cancer. 2010. PMID: 19739117 Free article.

8

Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.

Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O'Sullivan B, Waldron J, Gullane P, Cummings B, Liu FF. Hui AB, et al. Among authors: shi w. Clin Cancer Res. 2010 Feb 15;16(4):1129-39. doi: 10.1158/1078-0432.CCR-09-2166. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145181

9

MicroRNA-301 mediates proliferation and invasion in human breast cancer.

Shi W, Gerster K, Alajez NM, Tsang J, Waldron L, Pintilie M, Hui AB, Sykes J, P'ng C, Miller N, McCready D, Fyles A, Liu FF. Shi W, et al. Cancer Res. 2011 Apr 15;71(8):2926-37. doi: 10.1158/0008-5472.CAN-10-3369. Epub 2011 Mar 10. Cancer Res. 2011. PMID: 21393507

10

Significance of dysregulated metadherin and microRNA-375 in head and neck cancer.

Hui AB, Bruce JP, Alajez NM, Shi W, Yue S, Perez-Ordonez B, Xu W, O'Sullivan B, Waldron J, Cummings B, Gullane P, Siu L, Liu FF. Hui AB, et al. Among authors: shi w. Clin Cancer Res. 2011 Dec 15;17(24):7539-50. doi: 10.1158/1078-0432.CCR-11-2102. Epub 2011 Oct 26. Clin Cancer Res. 2011. PMID: 22031094

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,432 results

Search Page